A study of over 35,000 women with breast cancer tested with a 25‐gene panel of hereditary cancer genes-Reference-Cited by-同舟云学术

A study of over 35,000 women with breast cancer tested with a 25‐gene panel of hereditary cancer genes

Published:2017-01-13 Issue:10 Volume:123 Page:1721-1730
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Buys Saundra S.¹,Sandbach John F.²,Gammon Amanda¹,Patel Gayle²,Kidd John³,Brown Krystal L.³,Sharma Lavania³,Saam Jennifer³,Lancaster Johnathan³,Daly Mary B.⁴

Affiliation:

1. University of Utah School of Medicine, Department of Internal Medicine and Huntsman Cancer InstituteSalt Lake City Utah

2. Texas Oncology AustinAustin Texas

3. Myriad Genetics, IncSalt Lake City Utah

4. Fox Chase Cancer CenterPhiladelphia Pennsylvania

Funder

Myriad Genetic Laboratories

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.30498

Reference40 articles.

1. Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

2. Meta-Analysis ofBRCA1andBRCA2Penetrance

3. Risks of cancer in BRCA1-mutation carriers

4. KainuT JuoSH DesperR et al.Learning about the BRCAX study.2012. Accessed January 22 2014.http://www.genome.gov/10000532.

5. Hereditary breast cancer: ever more pieces to the polygenic puzzle

Cited by 311 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutation Spectrum Comparison between Benign Breast Lesion Cohort, Unselected Cancer Cohort and High-Risk Breast Cancer Cohort;Cancers;2024-09-03

2. Tracking the epidemiological trends of female breast cancer in Saudi Arabia since 1990 and forecasting future statistics using global burden of disease data, time-series analysis;BMC Public Health;2024-07-22

3. Ataxia telangiectasia-mutated rs56009889 and risk of common cancers;European Journal of Cancer Prevention;2024-07-16

4. Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes;Cancers;2024-06-27

5. Peripheral immunophenotyping reveals lymphocyte stimulation in healthy women living with hereditary breast and ovarian cancer syndrome;iScience;2024-06